Abstract
SLC6A4, which encodes the serotonin transporter, has a functional polymorphism called the serotonin transporter-linked polymorphic region (5-HTTLPR). The 5-HTTLPR consists of short (S) and long (L) alleles, each of which has 14 or 16 tandem repeats. In addition, the extralong (XL) and other rare alleles have been reported in 5-HTTLPR. Although they are more frequent in Asian and African than in other populations, the extent of variations and allele frequencies (AFs) were not addressed in a large population. Here, we report the AFs of the rare alleles in a large number of Japanese subjects (Nā=ā2894) consisting of two cohorts. The first cohort (case-control study set, CCSS) consisted of 1366 subjects, including 485 controls and 881 patients with psychosis (bipolar disorder or schizophrenia). The second cohort (the Arao cohort study set, ACSS) consisted of 1528 elderly subjects. During genotyping, we identified 11 novel 5-HTTLPR alleles, including 3 XL alleles. One novel allele had the longest subunit ever reported, consisting of 28 tandem repeats. We named this XL28-A. An in vitro luciferase assay revealed that XL28-A has no transcriptional activity. XL28-A was found in two unrelated patients with bipolar disorder in the CCSS and one healthy subject in the ACSS who did not show depressive symptoms or a decline in cognitive function. Therefore, it is unlikely that XL28-A is associated with psychiatric disorders, despite its apparent functional deficit. Our results suggest that unraveling the complex genetic variations of 5-HTTLPR will be important for further understanding its role in psychiatric disorders.
Introduction
The serotonin transporter (5-HTT) encoded by SLC6A4 is a key molecule that regulates serotonergic neurotransmission at the synaptic cleft, affecting emotions and stress responses. Therefore, numerous studies have focused on elucidating the pathophysiological implications of psychiatric disorders. Animal studies using constitutive Slc6a4 knockout mice showed increased anxiety-like phenotypes in various behavioral tests1,2,3. Furthermore, human studies indicate that dysregulation of 5-HTT in the serotonergic system is implicated in the emotional and behavioral disturbances of psychiatric disorders, including anxiety, depression, bipolar disorders (BD), schizophrenia (SZ), and autism4.
SLC6A4 has a functional polymorphism (serotonin transporter-linked polymorphic region, 5-HTTLPR) in its promoter region. 5-HTTLPR consists of two major alleles: the short (S) and the long (L), each of which has 14 or 16 repeat units5, composed of 20ā23ābp of highly homologous sequence units6, with the S allele exhibiting weaker transcriptional activity than the L allele7,8,9. On the basis of the dichotomous classification, myriad case-control association studies have been performed. Most of the studies and several meta-analyses claimed that the S allele confers sensitivity to environmental stress, which in turn increases vulnerability to anxiety and depressive symptoms10,11,12, although it remains controversial13,14, and the recent largest meta-analysis and case-control studies failed to replicate this finding15,16.
In addition to the major S and L alleles, 5-HTTLPR has a number of rare variants. To date, extrashort (XS) repeats (11ā13 repeats)17,18,19, 15 repeats5,19, and extralong (XL) repeats (17ā24 repeats)5,18,19,20,21,22,23,24,25,26 have been reported. These rare variants showed a higher frequency in Asian and African populations than in European and Native American populations19,27. However, despite the extensive genetic studies on 5-HTTLPR so far, the extent of variations and allele frequencies (AFs) have not been addressed in detail in a large population.
Here, we report the patterns and AFs of 5-HTTLPR rare variants in the Japanese population in detail. Through the genotyping of two cohorts, we examined 5-HTTLPR in a total of 2894 Japanese subjects. The first cohort (the case-control study set, CCSS) consisted of 1366 subjects, including 485 controls and 881 patients with major psychosis (BD and SZ). The second cohort (the Arao cohort study set, ACSS) consisted of 1528 subjects who are community-dwelling elderly individuals. In total, we identified 11 novel 5-HTTLPR alleles. One of the novel alleles had the longest subunit ever reported, consisting of 28 tandem repeats. We named this extremely long allele XL28-A. Interestingly, a luciferase reporter assay confirmed that XL28-A has no transcriptional activity. XL28-A was found in two unrelated patients with BD in the CCSS and one subject in the ACSS, who did not show depressive symptoms or a decline in cognitive functions. Therefore, it is unlikely that XL28-A is associated with psychiatric disorders, despite its apparent functional deficit. Our results suggest that unraveling and interpreting the complex genetic variations of 5-HTTLPR will be important for further understanding its role in psychiatric disorders.
Materials and methods
Study subjects
We used two independent Japanese DNA sample sets to examine the genetic variations of 5-HTTLPR. The first sample set (the CCSS) consisted of 1366 subjects, including 485 controls (CTs) and 881 patients with major psychosis (450 BD and 431 SZ). The details of the CCSS were previously reported28. All patients were diagnosed according to the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) criteria by experienced psychiatrists. CTs were collected based on voluntary recruitments from employees, students, and their friends and were interviewed by senior psychiatrists. All CTs were confirmed to have met the following criteria: (i) no current or past Axis-I psychiatric or physical diagnoses and (ii) no first-degree relatives with SZ or BD. For both patients and CTs, we excluded subjects with a history of current and past neurological illnesses, traumatic brain injuries, electroconvulsive therapy, and substance abuse.
The second sample set (the ACSS) consisted of 1528 elderly subjects. The ACSS addresses community-dwelling Japanese individuals aged over 65 who live in Arao city in Kumamoto prefecture in Japan. This is a part of the Japan Prospective Studies Collaboration for Aging and Dementia. Among the endpoints available, we utilized the Mini-Mental State Examination (MMSE)29 and Geriatric Depression Scale (GDS)30 for this study. These data are collected for the purpose of examining the baseline dementia or depression level at the start of the project.
The ethics committees of Kumamoto University and other collaborative research organizations approved this study. All subjects received a detailed description of this study and provided written informed consent.
DNA extraction and genotyping
Extraction of genomic DNA from peripheral blood cells (PBCs) and genotyping in the CCSS were previously reported28 and are briefly summarized in the Supplementary Methods. In the ACSS, genomic DNA was extracted from PBCs with a QIAamp DNA Blood Mini QIAcube Kit (Qiagen, Hilden, Germany) using a QIAcube (Qiagen). 5-HTTLPR was amplified with the following primers: FWD 5ā²-CTTTGCGTTTTCTGTTGCCCā3ā² and REV 5ā²-GGAGGCCAGGAACGATAGGAā3ā². PCR amplification was performed in a total volume of 20āµL solutions containing the following compositions: 10āµL of 2Ć PCR buffer for KOD FX (TOYOBO, Osaka, Japan), 4āµL of 12āmM dNTP mix, 0.6āµL each of 10āµM primers, 2āU of KOD FX (TOYOBO) and 10āng of genomic DNA. The thermocycling conditions were as follows: an initial cycle of 2āmin at 94ā°C, followed by 30 cycles of 10ās at 98ā°C and 1āmin at 68ā°C. All PCR amplicons were analyzed by MultiNA (SHIMAZU, Kyoto, Japan) and by bidirectional Sanger sequencing with 5ā²-GGCGTTGCCGCTCTGAATGCā3ā² or 5ā²-CAGGGCGGGGACCGCAAGGTā3ā². In some amplicons, we additionally performed TA cloning using a TOPO cloning kit (Invitrogen, Carlsbad, CA) followed by Sanger sequencing analysis of individual colonies.
Plasmid construction
The target 5-HTTLPR variant was amplified with the following primers: FWD 5ā²-AAgagctcGGTGAAATTCCCAAGCTTGTTG-3ā² with the SacI site (lowercase letters) and REV 5ā²AActcgagTTCTGGTGCCACCTAGACGC-3ā² with the XhoI site (lowercase letters). PCR amplification was performed in a total volume of 25āµL solutions containing the following compositions: 2.5āµL of 10 Ć PCR buffer for KOD-Plus-Neo (TOYOBO), 1.5āµL of 25āmM MgSO4 (Promega, Madison, WI, USA), 0.5āµL of 10āmM dNTP mix (Invitrogen), 2āµL each of 10āµM primers, 0.5 U of KOD-Plus-Neo (TOYOBO) and 50āng of genomic DNA. The thermocycling conditions were as follows: (1) an initial cycle of 2āmin at 94ā°C, (2) 33 cycles of 10ās at 98ā°C and 30ās at 72ā°C. The PCR fragments were gel-purified with a MinElute Gel Extraction Kit (Promega) followed by 3ā² A-attachment with TaKaRa Ex Taq (Takara, Tokyo, Japan) and cloned into the PCR 2.1 vector using the TOPO cloning kit. The SacI and XhoI fragments were subcloned into the pGL4.10 firefly luciferase reporter vectors (Promega). The single bacterial colony was cultured in a large volume, and the plasmid vector was purified with an Endotoxin-free plasmid DNA purification kit (NucleoBond Xtra EF purification system, Macherey-Nagel GmbH, Düren, Germany), followed by ethanol precipitation. All constructs were bidirectionally sequenced to check for proper orientation, sequence specificity and the absence of artificial mutations.
Luciferase reporter assay
Undifferentiated rat raphe-derived RN46 cell lines (Sigma-Aldrich, St. Louis, MO, USA) grown under standard conditions were cotransfected with 2āµg of each luciferase reporter construct, 200āng of the pGL4.73 Renilla luciferase reporter vector (Promega) as an internal control, and 200āng of pCMV-EGFP vector as a positive control using an electroporator (NEPA21, NEPA GENE, Tokyo, Japan). Twenty-four hours after transfection, cells were harvested and lysed, and luciferase activity was measured using a Dual Luciferase Assay System (Promega) and a GloMax⢠96 Microplate Luminometer (Promega) following the manufacturerās protocol. Each construct was transfected three times in each of three assays for a total of 9 independent transfections. Firefly/Renilla ratios were calculated in each transfection and normalized to the mean ratio of blank control vectors, pGL4.10 (Promega).
Results
Identification of novel variants of 5-HTTLPR in the CCSS
We previously performed genotyping of 5-HTTLPR in 1366 subjects of the CCSS and reported the epigenetic role of major alleles, including Asian-specific L16-C28. In this study, we examined rare alleles (AFā<ā5%) and found three known S variants (S14-B, S14-D and S14-E), one known L variant (L16-B), and three known XL alleles (XL19-A, XL20-A, and XL22-A). In addition, we identified seven novel alleles (S14-H, S15-D, S15-E, L16-I, L16-L, XL22-C, and XL28-A) (Fig. 1A, B). Representative alleles were visualized by electrophoresis on agarose gel (Fig. 1C).
A Names, genetic architecture, and allele frequencies of 5-HTTLPR alleles identified in this study. The allele names refer to the comprehensive summary of 5-HTTLPR alleles6, and individual repeat units are identified by the Greek-letter nomenclature introduced by Nakamura et al5. Novel alleles are underlined. The total number of alleles and their allele frequencies (%) are given. CCSS: case-control study set, ACSS: Arao cohort study set. B Structure of repeat units. Each repeat unit is assigned a Greek letter following the nomenclature of Nakamura et al. The nucleotide sequence of ζ is shown in bold. Nucleotide substitutions are highlighted in light gray, and insertions are in dark gray compared to ζ. Dark boxes in novel repeat units indicate nucleotide substitutions or insertions compared to the original repeat units. C Representative 5-HTTLPR genotypes in agarose gel electrophoresis. The lengths of the PCR amplicons are as follows: S14-A, 457ābp; S15-E, 479ābp; L16-A, 499ābp; L16-D, 499ābp; XL19-A, 567ābp; XL20-A, 583ābp; XL22-A, 625ābp; and XL28-A, 751ābp.
Structure of the novel 5-HTTLPR alleles in the CCSS
Among the novel alleles, S14-H, L16-I, L16-L, and S15-D were likely to be generated from base substitutions in the known repeat units. S14-H has a T/C substitution at the 12th base position in ι of the common S14-A allele. L16-I has a C/T substitution at the 7th base position in Īæ of the common L16-A allele. L16-L has a C/T substitution at the 22nd base position in ξ of L16-A. On the other hand, S15-D was generated by single-base cytosine insertion at the end of Ļ of S15-A6. Each of these mutated repeat units in S14-H, L16-I, L16-L, and S15-D was described as ιā, Īæā, ξā, and Ļā, respectively (Fig. 1B).
The other three novel alleles, S15-E, XL22-C, and XL28-A, were likely to be generated from novel arrangements of the known repeat units. S15-E contains a tandem duplication of a single η repeat compared with S14-A. XL22-C has a replacement of ξ with θ at the place of the 8th repeat unit in XL22-A. XL28-A has tandem duplications of eight ζ-η units compared with the one ζ-η unit allele S14-A.
Allele frequencies of the rare variants in psychosis in the CCSS
AFs with regard to diagnostic groups are listed in Supplementary Table 1. Using Fischerās exact test, none of the rare variants (AFā<ā5%), including novel alleles, showed significant deviation in patients compared to controls (pāā„ā0.05). Nonetheless, among the seven novel alleles, XL28-A was found in two unrelated patients with BD and not in controls. Considering that XL28-A is the longest allele so far identified, we performed a functional assay of this allele.
Functional characterization of XL28-A using a luciferase reporter assay
We examined the promoter activities of XL28-A and four known alleles (S14-A, L16-C, XL20-A, and XL22-A) using a luciferase reporter assay in the rat raphe-derived RN46 cell line. Each allele has a different number of ζ-η tandem repeats from one to eight (Fig. 1A, Table 1). We observed that the promoter activity was maintained as the number of tandem repeats was up to 5, with a slight decrease in longer repeats. However, we found that the promoter activity of XL28-A with 8 tandem repeats was at the same level as a blank control vector, indicating that XL28-A has no apparent promoter activity (Table 1).
Validation of XL28-A in the general population
We then extensively screened for the presence of XL28-A and other rare alleles using the ACSS (Nā=ā1528). Through genotyping in the ACSS, we found six novel alleles (S14-G, L16-I, L16-J, L16-K, XL20-F and XL28-A). Among them, two alleles, L16-I and XL28-A, were already found in the CCSS, and the other four were newly identified in this cohort (Fig. 1A). By combining the subjects of the CCSS and the ACSS, none of the rare alleles showed significant deviation in patients compared to controls by Fisherās exact test (pāā„ā0.05).
Structure of the novel 5-HTTLPR alleles (S14-G, L16-J, L16-K, and XL20-F) in the ACSS
S14-G has a C/T substitution at the 19th base position in ε of S14-A. L16-J has two consecutive C/T substitutions at the 8th and 9th base positions in Īæ of L16-A. These mutated repeat units were described as εā and Īæā (Fig. 1B). L16-K has a replacement of Ļ with Īæ or Ī· at the place of the 7th repeat unit in L16-A or L16-C. XL20-F has an insertion of a Īø-ι unit between the 7th and 8th repeat units in XL18-A6.
Relationship between the novel 5-HTTLPR alleles and either MMSE or GDS in elderly subjects
Among the endpoints available in the ACSS, we utilized MMSE and GDS. A subject harboring the XL28-A showed that both scores were at normal levels and within the normal variation in the ACSS population (Fig. 2). In addition, we observed that the other five novel alleles also did not show the possibility of major depressive disorder or dementia.
Scores of the MMSE and GDS are plotted. Colors indicate the total number of subjects. Arrows indicate the scores of subjects with novel alleles. The dotted line indicates the general thresholds of the MMSE (<ā23) and GDS (>ā8). Scores above (MMSE) and below (GDS) the thresholds indicate that the subject has no decline in cognitive function or no tendency toward depression. All indicated subjects had a novel allele that was heterozygous with S14-A.
Discussion
In this study, we identified a total of 11 novel rare alleles and obtained the AFs of known rare alleles of 5-HTTLPR in two independent Japanese cohorts. Among the reported rare alleles, we did not observe 11, 17, 21, and 24 repeat alleles, which were found in other ethnic populations18,24,25. We also did not observe 13 and 18 repeat alleles, which were reported in Japanese subjects19,31,32. Considering the sample sizes, our study achieved the most accurate and comprehensive estimation of the rare alleles in the Japanese population.
Genetic sequence and architecture of novel allelic variants
Among the 11 novel alleles, 8 were estimated to originate from either L16-A or S14-A. In addition, variable duplication of ζ-η subunits was involved in the other three alleles. XL28-A has eight ζ-η unit repeats inside the genomic rearrangement region, while S14-A has only one ζ-η unit. The exact duplications of the ζ-η unit have been identified in L16-C, XL18-A, XL20-A, XL20-E, and XL22-A. It would be reasonable to expect the presence of other intermediate numbers of repeat units with tandem duplications of ζ-η, such as 24 and 26.
XL28-A lost its promoter activity
Our promoter assay revealed that the extremely long XL28-A, which harbors 8 ζ-Ī· tandem repeats, had no promoter activity, while other alleles with a smaller number of repeats maintained their activities (Table 1). A previous study demonstrated that lymphoblastoid cell lines (LCLs) derived from American-African females homozygous or heterozygous with XL alleles, which are 81ābp longer than the L allele and presumably XL with 20 repeats, represent higher expression levels compared to those with SS or LL33. This result raised the hypothesis that an increased length of the 5-HTTLPR allele is associated with increased promoter activity. Our contrary result would be explained by the fact that the expression level in the previous study was affected by other regulatory polymorphisms, such as StIn234 and rs25531 SNP35, in SLC6A4. Another possibility would be that we only examined ζ-Ī· tandem repeats, and the XL alleles consisting of other units may exhibit a length-dependent increase in promoter activity.
Using the transcription factor binding profile database JASPAR (http://jaspar.genereg.net/), we found that the ζ-η tandem repeat has presumptive binding sites of the TFAP2 family, consisting of five members: TFAP2α, TFAP2β, TFAP2γ, TFAP2Γ, and TFAP2ε. It is known that TFAP2 proteins have essential roles in neuronal development36,37. In humans and mice, TFAP2β exists in the cerebellum, midbrain, medulla, and pons throughout adulthood38 and represses the promoter activity of SLC6A4 via the TFAP2 binding site at the rs25531 SNP of unit μ in L16-D39. Given that the presumptive TFAP2 binding site we found in this study is located over the ζ and η units, the accumulation of ζ-η tandem repeats might lead to the repression of the promoter activity of SLC6A4.
Pathophysiological role of the XL alleles
In the CCSS, we found no evidence of an association of the AF of XL alleles with BD or SZ. Contrary to our initial expectation, our extensive genotyping in the ACSS showed that the AF of XL28-A was not associated with psychiatric disorders. In addition, a subject with XL28-A did not show an apparent decline in cognitive function, nor was there a signature of depression in the elderly subjects. The absence of promoter activity of 5-HTTLPR, therefore, has no apparent effect on phenotypes related to psychiatric disorders. This would be explained by complementation by other cis-regulatory elements, such as StIn234 and rs25531 SNP35, in SLC6A4 and/or by another 5-HTTLPR allele. Therefore, it would be interesting to pursue the functionality by generating cells with homozygous XL28-A.
Our results suggest that the identification and interpretation of numerous 5-HTTLPR genetic variations will be important for understanding the role of 5-HTTLPR in psychiatric disorders. We have previously reported that psychiatric patients harboring low-activity alleles showed altered DNA methylation at specific CpG sites in SLC6A4 and altered amygdala volume28. Integrative analysis of DNA methylation and 5-HTTLPR as well as brain structure will be worth studying in the future.
References
Lira, A. et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54, 960ā971 (2003).
Holmes, A., Lit, Q., Murphy, D. L., Gold, E. & Crawley, J. N. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2, 365ā380 (2003).
Zhao, S. et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 140, 321ā334 (2006).
Gelernter, J. SLC6A4 polymorphism, population genetics, and psychiatric traits. Hum. Genet. 133, 459ā461 (2014).
Nakamura, M., Ueno, S., Sano, A. & Tanabe, H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5, 32ā38 (2000).
Iurescia, S., Seripa, D. & Rinaldi, M. Role of the 5-HTTLPR and SNP promoter polymorphisms on serotonin transporter gene expression: a closer look at genetic architecture and in vitro functional studies of common and uncommon allelic variants. Mol. Neurobiol. 53, 5510ā5526 (2016).
Lesch, K. P. et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527ā1531 (1996).
Heils, A. et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621ā2624 (1996).
Heils, A., Mossner, R. & Lesch, K. P. The human serotonin transporter gene polymorphismābasic research and clinical implications. J. Neural Transm. 104, 1005ā1014 (1997).
Uher, R. & McGuffin, P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry 15, 18ā22 (2010).
Karg, K., Burmeister, M., Shedden, K. & Sen, S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68, 444ā454 (2011).
Sharpley, C. F., Palanisamy, S. K., Glyde, N. S., Dillingham, P. W. & Agnew, L. L. An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings. Behav. Brain Res. 273, 89ā105 (2014).
Munafo, M. R., Durrant, C., Lewis, G. & Flint, J. Gene X environment interactions at the serotonin transporter locus. Biol. Psychiatry 65, 211ā219 (2009).
Risch, N. et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301, 2462ā2471 (2009).
Culverhouse, R. C. et al. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol. Psychiatry 23, 133ā142 (2018).
Border, R. et al. No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am. J. Psychiatry 176, 376ā387 (2019).
Frisch, A. et al. A rare short allele of the serotonin transporter promoter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan origin. Psychiatr. Genet. 10, 179ā183 (2000).
Ehli, E. A., Hu, Y., Lengyel-Nelson, T., Hudziak, J. J. & Davies, G. E. Identification and functional characterization of three novel alleles for the serotonin transporter-linked polymorphic region. Mol. Psychiatry 17, 185ā192 (2012).
Murdoch, J. D., Speed, W. C., Pakstis, A. J., Heffelfinger, C. E. & Kidd, K. K. Worldwide population variation and haplotype analysis at the serotonin transporter gene SLC6A4 and implications for association studies. Biol. Psychiatry 74, 879ā889 (2013).
Kunugi, H. et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol. Psychiatry 2, 457ā462 (1997).
Delbruck, S. J. et al. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet. Cell Genet. 79, 214ā220 (1997).
Michaelovsky, E. et al. A novel allele in the promoter region of the human serotonin transporter gene. Mol. Psychiatry 4, 97ā99 (1999).
Delbruck, S. J., Kidd, K. U. & Hoehe, M. R. Identification of an additional allelic variant (XLS) of the human serotonin transporter gene (SLC6A4): -1201Cins66. Hum. Mutat. 17, 524 (2001).
Rasmussen, H. B. & Werge, T. M. Novel procedure for genotyping of the human serotonin transporter gene-linked polymorphic region (5-HTTLPR)āa region with a high level of allele diversity. Psychiatr. Genet. 17, 287ā291 (2007).
Avula, R., Rand, A., Black, J. L. & OāKane, D. J. Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants. Transl. Psychiatry 1, e32 (2011).
Zhang, X. et al. Serotonin transporter polymorphic region 5-HTTLPR modulates risk for Parkinsonās disease. Neurobiol. Aging 35, 1957.e9ā1957.e14 (2014).
Haberstick, B. C. et al. Population frequencies of the triallelic 5HTTLPR in six ethnicially diverse samples from North America, Southeast Asia, and Africa. Behav. Genet. 45, 255ā261 (2015).
Ikegame, T. et al. Promoter activity-based case-control association study on SLC6A4 highlighting hypermethylation and altered amygdala volume in male patients with schizophrenia. Schizophr. Bull. 46, 1577ā1586 (2020).
Folstein, M. F., Folstein, S. E. & McHugh, P. R. āMini-mental stateā. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189ā198 (1975).
Yesavage, J. A. et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17, 37ā49 (1982).
Gelernter, J., Kranzler, H. & Cubells, J. F. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum. Genet. 101, 243ā246 (1997).
Narita, N. et al. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 107, 690ā692 (2001).
Vijayendran, M. et al. The relationship of the serotonin transporter (SLC6A4) extra long variant to gene expression in an African American sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159b, 611ā612 (2012).
Hranilovic, D. et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol. Psychiatry 55, 1090ā1094 (2004).
Hu, X. Z. et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78, 815ā826 (2006).
Mitchell, P. J., Timmons, P. M., Hebert, J. M., Rigby, P. W. & Tjian, R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5, 105ā119 (1991).
Moser, M., Ruschoff, J. & Buettner, R. Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev. Dyn. 208, 115ā124 (1997).
Coelho, D. J. et al. Cell type-specific and sexually dimorphic expression of transcription factor AP-2 in the adult mouse brain. Neuroscience 134, 907ā919 (2005).
Ivorra, J. L. et al. Association between neonatal temperament, SLC6A4, DRD4 and a functional polymorphism located in TFAP2B. Genes Brain Behav. 10, 570ā578 (2011).
Acknowledgements
We would like to thank the following researchers for the sample collection: Akane Yoshikawa, Fumichika Nishimura, and Yoshiya Kawamura. This work was partly supported by Japan Society for the Promotion of Science KAKENHI (16H06395, 16H06399, 16K21720, 18H02753, 18H05428, 18H05430, 18H05435, 18K07567, and 19K17056) and AMED (JP20dm0107097, JP20km0405201, JP20km0405208, JP20dm0107123, JP20dm0207074, JP20dk0207025, JP20dm0307001, JP20dm0307004, and JP20dm0207069). This work was supported in part by UTokyo Center for Integrative Science of Human Behavior (CiSHuB), and by the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleās Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleās Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ikegame, T., Hidaka, Y., Nakachi, Y. et al. Identification and functional characterization of the extremely long allele of the serotonin transporter-linked polymorphic region. Transl Psychiatry 11, 119 (2021). https://doi.org/10.1038/s41398-021-01242-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-021-01242-9